Evidence map›Paper›PMID 34386857›Full record

ArticleClinical oral investigations2022

Antineoplastic agents aggravate the damages caused by nicotine on the peri-implant bone: an in vivo histomorphometric and immunohistochemical study in rats.

Juliano Milanezi de Almeida, Edilson Ervolino, David Jonathan Rodrigues Gusman, Luiz Guilherme Fiorin, Breno Edson Sendão Alves, Fernando Pozzi Semeghini Guastaldi, Henrique Rinaldi Matheus

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Clinical oral investigations, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Juliano Milanezi de AlmeidaDepartment of Diagnosis and Surgery-Periodontics Division, School of Dentistry, São Paulo State University (Unesp), St. José Bonifácio 1193, Vila Mendonça, Araçatuba, SP, 16015-050, Brazil. jumilanezi@hotmail.com.ORCID http://orcid.org/0000-0002-5995-5747
Edilson ErvolinoNucleus of Study and Research in Periodontics and Implantology (NEPPI), School of Dentistry, São Paulo State University (Unesp), Araçatuba, SP, Brazil.
David Jonathan Rodrigues GusmanDepartment of Diagnosis and Surgery-Periodontics Division, School of Dentistry, São Paulo State University (Unesp), St. José Bonifácio 1193, Vila Mendonça, Araçatuba, SP, 16015-050, Brazil.
Luiz Guilherme FiorinDepartment of Diagnosis and Surgery-Periodontics Division, School of Dentistry, São Paulo State University (Unesp), St. José Bonifácio 1193, Vila Mendonça, Araçatuba, SP, 16015-050, Brazil.
Breno Edson Sendão AlvesDepartment of Diagnosis and Surgery-Periodontics Division, School of Dentistry, São Paulo State University (Unesp), St. José Bonifácio 1193, Vila Mendonça, Araçatuba, SP, 16015-050, Brazil.
Fernando Pozzi Semeghini GuastaldiDepartment of Oral and Maxillofacial Surgery, Massachusetts General Hospital, Harvard School of Dental Medicine, MA, Boston, USA.
Henrique Rinaldi MatheusDepartment of Diagnosis and Surgery-Periodontics Division, School of Dentistry, São Paulo State University (Unesp), St. José Bonifácio 1193, Vila Mendonça, Araçatuba, SP, 16015-050, Brazil.ORCID http://orcid.org/0000-0003-3318-5980
Universidade Estadual Paulista (Unesp) · BRBoston University · US

Funding

fundação de amparo à pesquisa do estado de são paulo 2014/11427-8fundação de amparo à pesquisa do estado de são paulo 2017/11805-0
6 · The paper itself

Abstract

objectiveTo assess the interaction between chemotherapy and normal tissues is critical to assure quality of life during and after the treatment of cancer. This study evaluated the influence of cisplatin (CIS) and 5-fluorouracil (5-FU) over the peri-implant tissues around osseointegrated titanium implants in animals previously exposed to nicotine. Materials and methods One hundred twenty male rats were divided into two groups, receiving via subcutaneous injection, either physiological saline solution (PSS) (n = 30) or nicotine hemissulfate (NIC) (n = 90) for 30 days prior to implants' placement. One titanium implant (4.0 × 2.2 mm) was installed in each tibia of all animals. PSS and NIC were continued for 30 days after surgery. Five days after cessation, rats were subdivided into three subgroups in accordance with systemic treatments with either PSS, CIS, or 5-FU. Euthanasia was performed at 50, 65, and 95 days post-surgery. Histometric, histopathological, and immunohistochemical analyses were performed.

resultsNIC-CIS and NIC-5FU presented lower BIC (50, 65, and 95 days) and bone area fraction occupancy (BAFO) (65 and 95 days) than group NIC. Intense inflammatory infiltration, severe tissue breakdown, reduced expression of bone formation biomarkers, and upregulation of TRAP were observed in NIC-CIS and NIC-5FU when compared with group NIC. TRAP expression was significantly higher in NIC-5FU as compared with NIC-CIS at 50 and 95 days. Groups NIC, NIC-CIS, and NIC-5FU presented statistically significant negative impact in all outcome parameters than group PSS.

conclusionCIS and 5-FU severely disrupted the peri-implant tissues around osseointegrated implants in animals previously exposed to nicotine. CLINICAL RELEVANCE: Assessing the interaction between chemotherapy and normal tissues is critical to assure quality of life during and after the cancer treatment.

Indexed as

Antineoplastic AgentsDental ImplantsAnimalsMaleNicotineOsseointegrationQuality of LifeRatsTibiaTitaniumAntineoplastic AgentsDental ImplantsNicotineTitaniumAntineoplastic agentsCisplatinDental implantsFluorouracilNicotineOsseointegration

Identifiers

PMID34386857
OpenAlexW3192835236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.